361 related articles for article (PubMed ID: 28636704)
21. A cross-sectional study of emergency care utilization and associated costs of violent-related (assault) injuries in the United States.
Monuteaux MC; Fleegler EW; Lee LK
J Trauma Acute Care Surg; 2017 Nov; 83(5S Suppl 2):S240-S245. PubMed ID: 29065065
[TBL] [Abstract][Full Text] [Related]
22. Traumatic Brain Injury-Related Emergency Department Visits, Hospitalizations, and Deaths - United States, 2007 and 2013.
Taylor CA; Bell JM; Breiding MJ; Xu L
MMWR Surveill Summ; 2017 Mar; 66(9):1-16. PubMed ID: 28301451
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
[TBL] [Abstract][Full Text] [Related]
24. Emergency department visits related to Clostridium difficile infection: results from the nationwide emergency department sample, 2006 through 2010.
Pant C; Sferra TJ; Olyaee M; Gilroy R; Anderson MP; Rastogi A; Pandya PK; Deshpande A
Acad Emerg Med; 2015 Jan; 22(1):117-9. PubMed ID: 25545404
[TBL] [Abstract][Full Text] [Related]
25. Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.
Insinga RP; Itzler RF; Pellissier JM
Pharmacoeconomics; 2007; 25(2):155-69. PubMed ID: 17249857
[TBL] [Abstract][Full Text] [Related]
26. Trends in pelvic inflammatory disease emergency department visits, United States, 2006-2013.
Kreisel K; Flagg EW; Torrone E
Am J Obstet Gynecol; 2018 Jan; 218(1):117.e1-117.e10. PubMed ID: 29045851
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults.
Le P; Rothberg MB
JAMA Intern Med; 2018 Feb; 178(2):248-258. PubMed ID: 29297049
[TBL] [Abstract][Full Text] [Related]
28. Rising annual costs of dizziness presentations to U.S. emergency departments.
Saber Tehrani AS; Coughlan D; Hsieh YH; Mantokoudis G; Korley FK; Kerber KA; Frick KD; Newman-Toker DE
Acad Emerg Med; 2013 Jul; 20(7):689-96. PubMed ID: 23859582
[TBL] [Abstract][Full Text] [Related]
29. Identification of Emergency Care-Sensitive Conditions and Characteristics of Emergency Department Utilization.
Vashi AA; Urech T; Carr B; Greene L; Warsavage T; Hsia R; Asch SM
JAMA Netw Open; 2019 Aug; 2(8):e198642. PubMed ID: 31390036
[TBL] [Abstract][Full Text] [Related]
30. Trends in Costs of Care for Medicare Beneficiaries Treated in the Emergency Department From 2011 to 2016.
Burke LG; Burke RC; Epstein SK; Orav EJ; Jha AK
JAMA Netw Open; 2020 Aug; 3(8):e208229. PubMed ID: 32761159
[TBL] [Abstract][Full Text] [Related]
31. Trends in Emergency Department Visits and Charges for Gout in the United States between 2006 and 2012.
Jinno S; Hasegawa K; Neogi T; Goto T; Dubreuil M
J Rheumatol; 2016 Aug; 43(8):1589-92. PubMed ID: 27252429
[TBL] [Abstract][Full Text] [Related]
32. National Trends in Mental Health-Related Emergency Department Visits Among Youth, 2011-2020.
Bommersbach TJ; McKean AJ; Olfson M; Rhee TG
JAMA; 2023 May; 329(17):1469-1477. PubMed ID: 37129655
[TBL] [Abstract][Full Text] [Related]
33. Cost of Routine Herpes Simplex Virus Infection Visits to U.S. Emergency Departments 2006-2013.
Di Xia F; Fuhlbrigge M; Dommasch E; Joyce C; Mostaghimi A
West J Emerg Med; 2018 Jul; 19(4):689-692. PubMed ID: 30013705
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years.
Le P; Rothberg MB
Ann Intern Med; 2015 Oct; 163(7):489-97. PubMed ID: 26344036
[TBL] [Abstract][Full Text] [Related]
35. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.
White RR; Lenhart G; Singhal PK; Insinga RP; Itzler RF; Pellissier JM; Segraves AW
Pharmacoeconomics; 2009; 27(9):781-92. PubMed ID: 19757871
[TBL] [Abstract][Full Text] [Related]
36. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States: Comparison of Birth Cohorts Preceding and Following Varicella Vaccination Program Launch.
Leung J; Dooling K; Marin M; Anderson TC; Harpaz R
J Infect Dis; 2022 Oct; 226(Suppl 4):S470-S477. PubMed ID: 36265856
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
Curran D; Patterson B; Varghese L; Van Oorschot D; Buck P; Carrico J; Hicks K; Lee B; Yawn B
Vaccine; 2018 Aug; 36(33):5037-5045. PubMed ID: 30017145
[TBL] [Abstract][Full Text] [Related]
39. Trends in Visits to Acute Care Venues for Treatment of Low-Acuity Conditions in the United States From 2008 to 2015.
Poon SJ; Schuur JD; Mehrotra A
JAMA Intern Med; 2018 Oct; 178(10):1342-1349. PubMed ID: 30193357
[TBL] [Abstract][Full Text] [Related]
40. Incidence, Admission Rates, and Predictors, and Economic Burden of Adult Emergency Visits for Acute Pancreatitis: Data From the National Emergency Department Sample, 2006 to 2012.
Garg SK; Sarvepalli S; Campbell JP; Obaitan I; Singh D; Bazerbachi F; Singh R; Sanaka MR
J Clin Gastroenterol; 2019 Mar; 53(3):220-225. PubMed ID: 29629907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
